Trump Imposes 100% Tariffic on Branded Pharma From Oct 1 — What It Means for Sun Pharma, Cipla, Dr Reddy’s and Nifty Pharma?
In a surprise move on Sept. 25, 2025, U.S. President Donald Trump announced a 100% tariff on imports of branded or patented pharmaceutical products effective October 1, 2025 — unless the manufacturer has already started building a U.S. manufacturing plant. The announcement sent global markets reeling and hit Indian pharma counters hard, with major names like Sun Pharma , Cipla , and Dr Reddy’s seeing immediate share pressure. ( Reuters ) What Trump announced (quick facts) The tariff: 100% on imports of branded/patented pharmaceuticals starting Oct 1, 2025 . ( Reuters ) Carve-out: companies that have begun construction of U.S. manufacturing sites (defined as “breaking ground” or “under construction”) are reportedly exempt. ( Reuters ) Immediate market reaction Markets reacted quickly. The Nifty Pharma index and individual pharma stocks fell after the announcement — Reuters reports the Indian pharma index and stocks like Sun Pharma were down significantly, with Sun P...